NEVVI Medicare utilization intelligence

← back

BENASHER, DANIELM.D. NPI 1780927558 Clinician

Hematology-Oncology · HEMPSTEAD, NY

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 13 years since medical school (class of 2013, self-reported to CMS)
Location HEMPSTEAD, NY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 41 codes billed · 7,055 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20212026
NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC
2021–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2017-02

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0897 Injection, denosumab, 1 mg
88185 Flow cytometry technique for dna or cell analysis, each additional marker
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
82784 Gammaglobulin (immune system protein) measurement
82728 Ferritin (blood protein) level
83540 Iron level
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
82607 Cyanocobalamin (vitamin b-12) level
82746 Folic acid level, serum
83521 Measurement of immunoglobulin light chains
83550 Iron binding capacity
84100 Phosphate level
83615 Lactate dehydrogenase (enzyme) level
84550 Uric acid level, blood
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
85044 Red blood count, manual test
83735 Magnesium level
96372 Injection of drug or substance under skin or into muscle
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
84165 Protein measurement, serum
86334 Immunologic analysis technique on serum (immunofixation)
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
84443 Blood test, thyroid stimulating hormone (tsh)
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
88184 Flow cytometry technique for dna or cell analysis, first marker
96413 Administration of chemotherapy into vein, 1 hour or less
82378 Carcinoembryonic antigen (cea) protein level
83010 Haptoglobin (serum protein) level
96374 Injection of drug or substance into vein
82668 Erythropoietin (protein) level
84153 Psa (prostate specific antigen) measurement, total
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
82248 Bilirubin level, direct
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
84403 Testosterone (hormone) level, total
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.